Product Code: RP-ID-10059290 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10059290
Market Overview:
Global E- Prescribing Market Outlook 2030
The global e-prescribing market is estimated to be valued at around USD ~2.5 billion in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 26% (CAGR) over the forecast period 2022-2030. The need for opioid monitoring in countries like the United States, along with pressure to reduce neglect and adverse events (ADRs), is a major driver of market growth.
Among prescribing errors, prescribing errors are the biggest problem for healthcare professionals worldwide, accounting for more than 70% of errors reported by hospitals and general practitioners. Although these mistakes are not fatal, they can have serious adverse effects on the patient health. In addition to the risks associated with patient health, error identification is a major cause of medical and legal error allegations against professionals and physicians. The diagnostic request was marked as an error or error.
Electronic prescription systems can reduce these errors by about 86% in most scenarios. When prescribing, electronic prescribing technology provides patients and physicians with a complete medical history, enabling warning and warning systems to reduce the potential for errors. Encourage the development of electronic prescription technology.
Electronic Controlled Substance Prescribing (EPS) provides a transparent and safe system for the relatively easy prescribing of many controlled substances to patients who are legally required in case of abuse or fraud. For example, in 2018, the drug epidemic reached the scale of the crisis, costing the United States more than $500 billion annually.
Sircept estimates that government support will help the market recover. Develop for the next few years. For example, the Patient and Community Safety Act passed by the US Congress in 2018 requires electronic versions of all Medicare Section D controlled substances by January 2021.
PRODUCT OVERVIEW :
Based on product, the market is divided into solutions and services. The solution gained significant market share in the product segment in 2018 due to increased accessibility and higher software costs. The services sector is expected to experience significant growth over the forecast period and untapped opportunities in industry and development are the main growth drivers for the services sector.
For example, according to the Center for Health System Change Research (CSHSC), the lack of e-prescribing is a significant factor in outpatient settings due to incomplete patient data, technical complexity, and physician attitudes towards e-prescribing. in the electronic version. According to a 2017 SureScript survey, more than 70% of US hospitals are running electronically.
However, around 30% of physicians still prefer paper prescriptions, with integrated solutions accounting for the largest percentage in 2018. However, CAGR is expected to grow thanks to government-funded initiatives to implement integrated versions of version control solutions. The benefits and incentives provided by the federal government are expected to outweigh the cost of migrating from standalone to integrated systems, driving the growth of the integrated systems market.
OVERVIEW OF HOW IT IS DELIVERED :
Web/cloud-based electronic version control systems gained significant market share in 2018 due to lower cost than internal systems. Cloud platforms are an attractive option for general practitioners, small clinics, municipal clinics, and hospitals who cannot afford the high cost of internal systems. Cerner, Athenahealth, Allscripts, and eClinicalWorks are some of the healthcare IT companies offering cloud-based solutions to users.
Additionally, the ease of use of cloud solutions and reduced training needs are other drivers of cloud solutions growth, but large healthcare systems and organizations can store large amounts of data and pay higher costs. The system is a very reliable option. The growing demand for data security and the cost of sharing and digitization should overshadow the growth of internal solutions during this period. Epic and Cerner are the two major players in the electronics market.
END USE INFORMATION:
Hospitals hold a large market share in the end-use segment, primarily due to the abuse of these facilities. According to a 2016 American Association of Medical Pharmacists (ASHP) survey, more than 95% of patients have adopted technology to improve substance use through electronic prescription and transcription. About 392 American Hospitals American Hospitals.
Currently, more than 320,000 doctors nationwide prescribe e-prescribing, but according to Suscript, a successful transition from handwritten to e-prescribing may take longer than expected and the process will require delays. As system capabilities continue to evolve, experts and finalists may need ongoing support and training to maintain performance. This should increase the overall cost of technology and market growth.
USAGE SUMMARY :
Mobile devices dominate the market share due to their ease of use. Also in 2019, technological advances such as DrCirsts Rcopy system, which have been modified to be compatible with the small screens of mobile devices, including Apples iPhone, will support growth in the sector. .. Tablets, PDAs, and smartphones are preferred because of their easy access to electronic prescription labs. However, strategically placed computers are placed outside or inside the test room to adequately support the workflow and reduce the need for manual access. However, computers with large screens are usually preferred because multiple data can be viewed simultaneously to access the entire EHR. Content Insights: Managed content dominated the content market in 2018.
AS REPORTED BY SUPERSCRIPT:
Prescribing and monitoring controlled substances such as opiates ensures effective drug/substance use and often uses inappropriate registration practices such as drug addicts. , destroyed. These methods were widely adopted with approximately 45.3 million electronic prescriptions in 2016, a more than 200% increase from 12.8 million electronic prescriptions for controlled substances in 2015. In 2018, the US Congress approved this method.
Electronic Prescribing as an Essential Ingredients of Controlled Substances The government has adopted Substance Abuse Prevention, Recovery Support and Opioids (SAP), patient and community laws regulating controlled substances. This includes Medicare Apartment D. It will be transmitted electronically from January 2021. The discovery of electronic prescription software for non-regulated substances is expected to drive further growth in the industry during the forecast period.
EXPERT APPROACH :
Oncology held a large market share as a specialty in 2020. Mistakes in prescribing chemotherapy and chemotherapy can lead to fundamental errors. Most of these errors can be due to illegal regulations and incorrect documentation.
The increasing number of medical malpractice in chemotherapy has introduced technology for treating hospitals, especially oncology. For example, in 2016, IQMo of BMI Healthcare, a hospital association, installed Medical Knowledge Systems electronic cancer prescribing systems in 30 chemotherapy hospitals.
Additionally, government initiatives to promote the electronic version should boost market growth. For example, in 2018 the Australian Department of Health (EOI) invested in Victorias public health services and co-invested in the nationwide implementation of an electronic cancer prescription system. Meanwhile, the cardiac sector is expected to grow rapidly, driven by growing demand for electronic health records and electronic prescription systems, health insurance and RAMQ claims, and specific tests for medical issues. Markets in the forecast period driven by industry government initiatives and incentives.
Europe is the second largest market for e-prescription software, thanks to strict regulatory guidelines in European countries for neglect prevention. It is also necessary to double EU initiatives. Although many countries do not accept e-prescriptions from other countries, the European Union will allow doctors from other countries to use e-prescriptions when they go to pharmacies in other EU countries in 2019. Strict prescriptions such as negligence incentive programs and plaintiffs across the country are major drivers of overall market growth. For example, the UAE Ministry of Health banned the manuscript in 2018. The directive requires private health facilities to issue paper or electronic prescriptions.
EXPERET INSIGHTS:
Oncology held a large market share in the specialty sector in 2020. Basic errors can be caused by prescription chemotherapy drugs or cancer. Most of these errors are due to illegal regulations and incorrect documentation. The increasing number of medical negligence in chemotherapy has introduced technology for hospitals, especially for treating oncology. For example, in 2016, BMI Healthcare, a hospital network, installed Medical Knowledge System electronic cancer prescribing system in 30 chemotherapy hospitals.
Additionally, government initiatives promoting electronic versions are expected to boost the market growth. For example, in 2018 the Australian Department of Health (EOI) invested in Victoria's public health services and co-invested in the nationwide implementation of an electronic cancer prescription system. Meanwhile, the heart industry is expected to grow faster, driven by growing demand for electronic health records and electronic prescription systems for OHIP and RAMQ bill-specific testing and workflow issues.
REGIONAL OUTLOOK:
Given local government initiatives and incentives, North America is expected to dominate the market during the forecast period. Europe is the second largest market for e-prescription software, thanks to the strict regulatory directives of European countries for neglect prevention. We also need to double our EU initiatives. Although many countries do not allow electronic prescriptions from other countries, the European Union adopted a directive in 2019 allowing the use of electronic prescriptions issued by doctors from other countries during medical visits. “Pharmacies in other EU countries.
Strict prescriptions such as incentive programs and plaintiffs at the national level are important growth drivers at the market level due to the possibility of negligence. For example, the Ministry of Health and UAE preventive copy banned in 2018 Under the direction of this initiative, private health care institutions are required to issue prescriptions in paper or electronic format.
ELECTRONICS MARKET SHARE DESCRIPTION:
The market is highly competitive and a large number of players occupy the majority of the share. Faced with increasing patient awareness and the need to reduce neglect, and the continuing need to reduce costs and improve the quality of healthcare solutions, players are looking for innovative products to stay competitive.
A software solution for electronic recipes thanks to a wide range of products. The market is still developing and has high growth potential. Additionally, these companies are targeting emerging economies, which are expected to become important markets in the next few years. Some of the other major players are HealthFusion, Inc. and Clinical Works. AllScripts Healthcare Solutions, Inc. and Aprimas medical software.
SECTIONS INCLUDED IN THIS REPORT:
The report forecasts global revenue growth at the regional and country level and provides an analysis of the latest industry trends in each sub sector from 2022-2030 .. Global Analysis Report by Product, Field Distribution, End Use, Usage Patterns, Features and Geography of Multimedia and Electronic Versions: Product Forecast (Sales, $1 Million, 2022-2030), Education, Network, $US Mode, 2022-2030) Web/End-Use Forecast Cloud (Sales, 2022-2030) Hospital, Clinic, Pharmacy, Usage Forecast (Sales, Million Dollars, 2022-2030) Laptop Device Hardware Forecast (Sales, Million Dollars, 2022-2030) ) New Sports Medicine and Cardiology.
"
Related Reports
Proof of Quality & Reliability
